Voyager Therapeutics Inc (VYGR)
Investing Cash Flow
$105.80M
TTM · Period ending: · USD
VYGR Investing Cash Flow
Latest reported$105.80Mperiod ending
Latest reported$105.80Mperiod ending
VYGR TTM Cash from Investing (-$3.30M → $105.80M)
TTM investing cash flow
High-resolution chart · PNG
VYGR investing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| 105,804,000 | |
| 92,346,000 | |
| 125,446,000 | |
| 50,819,000 | |
| 80,283,000 | |
| 42,407,000 | |
| -94,859,000 | |
| -40,823,000 | |
| -263,479,000 | |
| -252,199,000 | |
| -141,643,000 | |
| -154,409,000 | |
| 38,617,000 | |
| 27,150,000 | |
| -7,339,000 | |
| -26,870,000 | |
| -47,252,000 | |
| 11,283,000 | |
| 65,906,000 | |
| 49,854,000 | |
| 62,870,000 | |
| 38,627,000 | |
| 112,995,000 | |
| 160,973,000 | |
| 156,227,000 | |
| 155,177,000 | |
| -90,477,000 | |
| -88,309,000 | |
| -112,112,000 | |
| -168,596,000 | |
| 26,467,000 | |
| -62,264,000 | |
| -63,839,000 | |
| 34,066,000 | |
| -3,681,000 | |
| 42,278,000 | |
| 51,657,000 | |
| 55,886,000 | |
| 47,300,000 | |
| -38,135,000 | |
| -55,259,000 | |
| -182,550,000 | |
| -194,769,000 | |
| -96,201,000 | |
| -86,969,000 | |
| -3,267,000 | |
| -3,302,000 |